1
Clinical Trials associated with AdC6-HIVgp140A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Vaccines Based on Chimpanzee Serotypes of Adenovirus Expressing Clade C gp140 and a CH505TF gp120 Protein Boost in Healthy, HIV- Uninfected Adult Participants
The purpose of this study is to evaluate the safety and immunogenicity of HIV-1 vaccines based on chimpanzee serotypes of adenovirus expressing clade C gp140 and a CH505TF gp120 protein boost in healthy, HIV- uninfected adult participants.
100 Clinical Results associated with AdC6-HIVgp140
100 Translational Medicine associated with AdC6-HIVgp140
100 Patents (Medical) associated with AdC6-HIVgp140
100 Deals associated with AdC6-HIVgp140